Intra-immusg Pte Ltd
Clinical trials sponsored by Intra-immusg Pte Ltd, explained in plain language.
-
New hope for macular degeneration patients who failed standard treatments
Disease control Recruiting nowThis early-stage study tests a new drug called PRL3-zumab in 15 people with wet age-related macular degeneration (nAMD) who did not improve with standard treatments. The drug is given through a vein every two weeks for three doses, and patients are monitored for 24 weeks. The goa…
Phase: PHASE1, PHASE2 • Sponsor: Intra-IMMUSG Pte Ltd • Aim: Disease control
Last updated May 26, 2026 09:23 UTC
-
New antibody drug targets advanced cancers in Mid-Stage trial
Disease control Recruiting nowThis study tests a new drug, PRL3-zumab, in 52 adults with advanced solid tumors that have not responded well to prior treatments. The drug is given every two weeks by IV. The main goal is to see how long the cancer stays under control and whether the drug is safe. This is not a …
Phase: PHASE2, PHASE3 • Sponsor: Intra-IMMUSG Pte Ltd • Aim: Disease control
Last updated May 15, 2026 11:57 UTC